Stockscreener 앱 받기
29.06
3.25%
-0.9435
전일 마감가:
$30.00
열려 있는:
$29.88
하루 거래량:
356.30K
Relative Volume:
0.21
시가총액:
$4.80B
수익:
$1.51B
순이익/손실:
$333.35M
주가수익비율:
14.90
EPS:
1.95
순현금흐름:
$315.22M
1주 성능:
+0.33%
1개월 성능:
+8.97%
6개월 성능:
-18.01%
1년 성능:
+2.71%
1일 변동 폭
$28.97
$29.89
1주일 범위
$28.89
$31.69
52주 변동 폭
$25.56
$36.45
Alkermes Plc Stock (ALKS) Company Profile
명칭
Alkermes Plc
전화
00-353-1-772-8000
주소
CONNAUGHT HOUSE, DUBLIN 4
ALKS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
29.05 | 4.85B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
151.98 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.23 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.8703 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.62 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
384.44 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 개시 | Goldman | Buy |
| 2025-06-17 | 업그레이드 | UBS | Neutral → Buy |
| 2025-05-28 | 개시 | Needham | Buy |
| 2025-03-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | 업그레이드 | UBS | Sell → Neutral |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-11-05 | 업그레이드 | Stifel | Hold → Buy |
| 2024-06-17 | 개시 | TD Cowen | Buy |
| 2024-03-19 | 개시 | Robert W. Baird | Outperform |
| 2024-02-20 | 다운그레이드 | UBS | Neutral → Sell |
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-10-24 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-10-17 | 개시 | UBS | Neutral |
| 2022-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-08-16 | 개시 | Piper Sandler | Neutral |
| 2022-04-22 | 재개 | Goldman | Buy |
| 2022-04-20 | 개시 | Goldman | Buy |
| 2022-01-27 | 업그레이드 | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | 개시 | Citigroup | Neutral |
| 2021-10-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-09-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-10-15 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-07-30 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-02-14 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | 재확인 | H.C. Wainwright | Neutral |
| 2020-02-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-02-06 | 개시 | Mizuho | Neutral |
| 2020-01-31 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-05-31 | 개시 | H.C. Wainwright | Neutral |
| 2019-05-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 다운그레이드 | Goldman | Neutral → Sell |
| 2018-12-14 | 개시 | Wolfe Research | Underperform |
| 2018-12-13 | 다운그레이드 | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | 개시 | Piper Jaffray | Neutral |
| 2018-08-07 | 개시 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
모두보기
Alkermes Plc 주식(ALKS)의 최신 뉴스
Is Alkermes plc stock technically oversoldGap Up & Safe Entry Zone Identification - khodrobank.com
What analysts say about Alkermes plc stockQuarterly Investment Review & Free High Return Stock Watch Alerts - khodrobank.com
Does Alkermes plc show high probability of rebound2025 Price Targets & Breakout Confirmation Trade Signals - Newser
What machine learning models say about Alkermes plcJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Benzinga
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Nanotechnology Drug Delivery Market Outlook (2025-2032) : - openPR.com
Wells Fargo Initiates Alkermes Public at Overweight With $44 Price Target - MarketScreener
Applying sector rotation models to Alkermes plcNew Guidance & Free Safe Entry Trade Signal Reports - Newser
Real time alert setup for Alkermes plc performanceBond Market & AI Driven Stock Movement Reports - Newser
How to integrate Alkermes plc into portfolio analysis toolsPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Will a bounce in Alkermes plc offer an exitQuarterly Market Review & Smart Allocation Stock Tips - Newser
How to use a screener to detect Alkermes plc breakouts2025 Top Gainers & Verified Momentum Stock Alerts - Newser
When is the best time to exit Alkermes plc2025 Market Outlook & Expert Curated Trade Setups - Newser
Identifying reversal signals in Alkermes plcMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser
Can swing trading help recover from Alkermes plc lossesPortfolio Growth Summary & High Accuracy Trade Alerts - Newser
Using Bollinger Bands to evaluate Alkermes plcTrade Volume Report & AI Driven Stock Reports - Newser
How cyclical is Alkermes plc’s revenue streamJuly 2025 Weekly Recap & Technical Pattern Based Signals - khodrobank.com
Multi asset correlation models including Alkermes plcLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
Analyzing recovery setups for Alkermes plc investorsWeekly Stock Summary & Daily Stock Trend Reports - Newser
How to track smart money flows in Alkermes plcJuly 2025 Market Mood & Weekly Setup with High ROI Potential - Newser
Does Alkermes plc qualify in momentum factor screening2025 Support & Resistance & Weekly Momentum Picks - Newser
Does Alkermes plc fit your quant trading modelQuarterly Earnings Summary & Low Risk Entry Point Guides - Newser
Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025 - Yahoo Finance
Visual trend scoring systems applied to Alkermes plcJuly 2025 Outlook & Reliable Intraday Trade Plans - Newser
How to manage a losing position in Alkermes plcWeekly Volume Report & Risk Managed Investment Strategies - Newser
Can Alkermes plc maintain sales growthWeekly Investment Recap & Reliable Breakout Stock Forecasts - khodrobank.com
Is Alkermes plc a top pick in the sectorCEO Change & Smart Money Movement Tracker - khodrobank.com
How Alkermes plc stock performs during market volatilityWeekly Trade Analysis & Accurate Technical Buy Alerts - Newser
Is Alkermes plc stock undervalued right now2025 Pullback Review & Fast Entry Momentum Alerts - khodrobank.com
Alkermes plc stock trend outlook and recovery pathEarnings Performance Report & Safe Capital Growth Trade Ideas - Newser
Sentiment analysis tools applied to Alkermes plcJuly 2025 WrapUp & Real-Time Market Sentiment Reports - Newser
How to read the order book for Alkermes plcShare Buyback & Fast Gain Stock Tips - Newser
Alkermes plc stock trend forecastExit Point & Weekly Watchlist of Top Performers - Newser
Will Alkermes plc benefit from macro trends2025 Macro Impact & AI Forecasted Stock Moves - Newser
Alkermes Plc (ALKS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Alkermes Plc 주식 (ALKS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nichols Christian Todd | SVP, Chief Commercial Officer |
Jun 10 '25 |
Sale |
31.09 |
3,334 |
103,654 |
86,208 |
0.37%
0.55%
자본화:
|
볼륨(24시간):